Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410232 | Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor | Nicola Mason, Mohammed Kazim Panjwani, Jenessa Smith, Laurence J.N. COOPER, Colleen M. O'Connor | 2025-09-09 |
| 12325756 | Use of trans-signaling approach in chimeric antigen receptors | Carl H. June | 2025-06-10 |
| 12240884 | Methods for improving the efficacy and expansion of immune cells | Felipe Bedoya, Saba Ghassemi, Carl H. June, Omkar U. Kawalekar, Bruce L. Levine +3 more | 2025-03-04 |
| 12227588 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Marco Ruella, Saar Gill, Carl H. June, Avery D. Posey | 2025-02-18 |
| 12122829 | Human alpha-folate receptor chimeric antigen receptor | Mariangela Figini, Silvana Canevari | 2024-10-22 |
| 11912753 | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens | Nathalie Scholler, Katarzyna Urbanska | 2024-02-27 |
| 11896614 | Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells | David Barrett, Felipe Bedoya, Saba Ghassemi, Carl H. June, Bruce L. Levine +4 more | 2024-02-13 |
| 11673964 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Marco Ruella, Saar Gill, Carl H. June, Avery D. Posey | 2023-06-13 |
| 11623088 | Devices and methods for the treatment of substance use disorders | Alejandro Covalin, Navid Khodaparast | 2023-04-11 |
| 11484552 | Use of trans-signaling approach in chimeric antigen receptors | Carl H. June | 2022-11-01 |
| 11377481 | SpyCatcher and SpyTag: universal immune receptors for T cells | Andrew Tsourkas | 2022-07-05 |
| 11351370 | Devices and methods for treating cognitive dysfunction and depression using electrical stimulation | Alejandro Covalin, Navid Khodaparast | 2022-06-07 |
| 11345735 | Fully-human t-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein | — | 2022-05-31 |
| 11180550 | Compositions and methods for treating cancer | George Coukos, Mariangela Figini, Silvana Canevari | 2021-11-23 |
| 11161907 | Car-expressing cells against multiple tumor antigens and uses thereof | Carl H. June | 2021-11-02 |
| 11116795 | Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor | Nicola Mason, Mohammed Kazim Panjwani, Jenessa Smith | 2021-09-14 |
| 11041012 | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens | Nathalie Scholler, Katarzyna Urbanska | 2021-06-22 |
| 10961288 | Isolated B7-H4 specific compositions and methods of use thereof | Nathalie Scholler, Denarda Dangaj, Aizhi Zhao | 2021-03-30 |
| 10900019 | CD137 enrichment for efficient tumor infiltrating lymphocyte selection | — | 2021-01-26 |
| 10844117 | Human alpha-folate receptor chimeric antigen receptor | — | 2020-11-24 |
| 10829735 | Methods for improving the efficacy and expansion of immune cells | Felipe Bedoya, Saba Ghassemi, Carl H. June, Omkar U. Kawalekar, Bruce L. Levine +3 more | 2020-11-10 |
| 10538568 | Methods and compositions of a follicle stimulating hormone receptor immunoreceptor | Caitlin Stashwick, Katarzyna Urbanska | 2020-01-21 |
| 10457729 | Compositions and methods for treating cancer | George Coukos, Mariangela Figini, Silvana Canevari | 2019-10-29 |
| 10414812 | Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein | — | 2019-09-17 |
| 10273300 | Methods of making chimeric antigen receptor-expressing cells | Felipe Bedoya, Saba Ghassemi, Carl H. June, Bruce L. Levine, Jan J. Melenhorst +2 more | 2019-04-30 |